Tipolo, Felomico .
HRN: 10-81-17 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/11/2023
CEFTRIAXONE 1G (VIAL)
08/11/2023
08/17/2023
IVT
2g
OD
T/c Nephrolithiasis
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes